1. Home >
  2. Companies >
  3. Distribution >
  4. Abacus Pharmaceuticals

Abacus Pharmaceuticals - Ownership and Business Overview

DistributionCompany

Abacus Pharmaceuticals Ownership

Who owns Abacus Pharmaceuticals?

Abacus Pharmaceuticals is owned by The Carlyle Group. It was acquired on September 13, 2018.

Is Abacus Pharmaceuticals PE-backed?

Yes. Abacus Pharmaceuticals is owned by private equity investor The Carlyle Group.

Abacus Pharmaceuticals Business Overview

Where is Abacus Pharmaceuticals headquartered?

Abacus Pharmaceuticals is headquartered in Lugogo Kampala, Uganda.

What sector is Abacus Pharmaceuticals in?

Abacus Pharmaceuticals is a distribution company.

When was Abacus Pharmaceuticals founded?

Abacus Pharmaceuticals was founded in 1995.

Distribution M&A Summary in 2018

Out of 60 sectors in the Mergr database, distribution ranked 10 in number of deals in 2018. The largest distribution acquisition in 2018 was KLX - which was acquired by The Boeing for $4.3B.

Subscribe to Mergr to view all 269 acquisitions of distribution companies in 2018, including 56 acquisitions by private equity firms, and 213 by strategics.

Abacus Pharmaceuticals

Abacus Pharma Ltd.

Plot No.28B-32B-34B, PO Box 31376 Coronation Avenue, UMA Show Grounds,
Lugogo Kampala,
Uganda,
+256 417 100 900
www.abacuspharma.com

Abacus Pharmaceuticals is a distributor of pharmaceutical products in East Africa and the largest manufacturer of parenterals (IV fluids, ear, eye and nose drops) in Uganda. The company has a differentiated product offering, ranging from mission critical parenterals to branded generics for chronic therapeutic areas such as oncology, diabetes and cardiovascular. Abacus Pharmaceuticals was founded in 1995 and is based in Lugogo Kampala, Uganda.


Company Summary

SECTOR

Distribution

Established

1995

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Abacus Pharmaceuticals

Distribution Companies

Related Lists for Distribution Companies

Largest Distribution Companies , Acquisitive Distribution Companies , Recently Acquired Distribution Companies , Recently Sold Distribution Companies , Private Distribution Companies , Public Distribution Companies , Acquired Distribution Companies , PE Backed Distribution Companies
Mergr

Solution for

Product

Company

Legal